Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches. (Q36730671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1 reference

attention deficit hyperactivity disorder

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Mohammad Reza Mohammadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

195-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17286552%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

What is attention-deficit/hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Attention-deficit/hyperactivity disorder and comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Diagnostic utility of DSM-IV-TR symptoms in the prediction of DSM-IV-TR ADHD subtypes and ODD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Attention-Deficit Hyperactivity Disorder in Girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Gender differences in ADHD: a meta-analysis and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Clinical Correlates of ADHD in Females: Findings From a Large Group of Girls Ascertained From Pediatric and Psychiatric Referral Sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Stimulant treatment for children: a community perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Non-stimulant medications in the treatment of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195

A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.2.195